← Back to headlines
Experimental Immunotherapy Shows Promising Results in Bowel Cancer Trial
Patients in a new bowel cancer immunotherapy trial have remained cancer-free for nearly three years after receiving pembrolizumab before surgery, marking a significant breakthrough.
4 May, 21:02 — 4 May, 21:02
